Cardiovascular Disease After Aromatase Inhibitor Use - Concepedia

Concepedia

Publication | Open Access

Cardiovascular Disease After Aromatase Inhibitor Use

DOI Full Paper Access

101

Citations

25

References

2016

Year

Reina Haque, Jiaxiao Shi, Joanne E. Schottinger, Joanie Chung, Chantal Avila, Britta Amundsen, Xiaoqing Xu, Ana Barac, Rowan T. Chlebowski

Abstract

The risk of the most serious cardiovascular events (cardiac ischemia or stroke) was not elevated in AI-only users compared with tamoxifen users. The finding that other CVD events combined were greater in AI users requires further study.

References

	Year	Citations
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Christina Davies, Hongchao Pan, Jon Godwin, The Lancet Breast OncologyLong-term EffectsMedicineRandomised TrialGynecology	2012	2K
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 Paul E. Goss, James N. Ingle, Silvana Martino, JNCI Journal of the National Cancer Institute	2005	1.1K
Exemestane for Breast-Cancer Prevention in Postmenopausal Women Paul E. Goss, James N. Ingle, José E. Alés‐Martínez, New England Journal of Medicine	2011	952
Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study Jennifer L. Patnaik, Tim Byers, Carolyn DiGuiseppi, Breast Cancer Research	2011	874
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update Harold J. Burstein, Sarah Temin, Holly Anderson, Journal of Clinical Oncology	2014	790
Surveillance and ascertainment of cardiovascular events Diane G. Ives, Annette L. Fitzpatrick, Diane E. Bild, Annals of Epidemiology	1995	684
A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario Peter C. Austin, Paul Daly, Jack V. Tu American Heart Journal NursingClinical DataClinical DatabaseHealth Care AnalyticsMedical Coding	2002	520
Estimating medication persistency using administrative claims data. Rishi Sikka, Fang Xia, Ronald E. Aubert PubMed	2005	456
Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial Jack Cuzick, Ivana Šestak, Simon Cawthorn, The Lancet Oncology	2014	451
Cardiovascular Disease Mortality Among Breast Cancer Survivors Patrick T. Bradshaw, June Stevens, Nikhil K. Khankari, Epidemiology	2015	436

Page 1